Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types

Authors

Kristen Hanson, Advocate Aurora HealthFollow
Michael P. Mullane MD, Advocate Aurora HealthFollow
Deborah Wham, Advocate Aurora HealthFollow
Michael A. Thompson, Advocate Aurora HealthFollow
Jennifer Godden, Advocate Aurora HealthFollow
Mary Walters, Advocate Aurora HealthFollow
et al

Recommended Citation

Hanson K, Mullane M, Schnettler E, et al. Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types. Journal of clinical oncology. 2021;39:10596-10596.

Affiliations

Advocate Aurora Health

Aurora Cancer Care, Advocate Aurora Health

Presentation Notes

Poster presented at: ASCO Annual Meeting 2021; June 2021; Chicago, IL

Document Type

Abstract